To view this email as a web page, click here.

 
Biologics for PsA not Associated with Higher Heart Disease Risk
Study shows there is no substantial difference in cardiovascular risk associated with different biologic therapies for psoriasis and psoriatic arthritis patients.
Read more
 
CV Risk in Rheumatic Diseases: 3 New Things
(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia
Read more
 
High Disease Activity in RA: A Danger Zone for Heart Disease and Infection
Good management of rheumatoid arthritis may also prevent serious infection, myocardial infarction, and even death related to comorbid disease.
Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.